The Defense Departments own Operation Supplement safety site warns service members to stay clear of products containing BPC-157, which are sold online as research chemicals and carry statements such as Not for human consumption, Research use only, or For research purposes only. The marketed benefits of BPC-157 have only been shown in lab or animal studies (rats, mice, and dogs), the DoD supplement site states
Semaglutide (Wegovy) is also used to treat metabolic dysfunction-associated steatohepatitis (MASH), without cirrhosis of the liver
State pharmacy and medical boards may add further requirements
Whilst the individual components (methionine, inositol, choline) play roles in lipid metabolism, there are no large-scale, peer-reviewed studies demonstrating that injectable formulations produce clinically meaningful weight loss or metabolic benefits
Many people find them convenient for on-the-go lifestyles or if they prefer a quicker procedure